- Home
- / YiChang HEC ChangJiang Pharmaceutical
YiChang HEC ChangJiang Pharmaceutical
Stock Price
$8.9
2024-10-29
Market Capitalization
$7.8 B
2024-10-29
Revenue
¥6.3 B
FY, 2023
YiChang HEC ChangJiang Pharmaceutical Summary
Company Summary
- Overview
- YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products. It focuses on virus infections, endocrine, metabolic, and cardiovascular diseases. The company offers its products in the form of capsules and granules.
- Type
- Public
- Status
- Active
- Founded
- 2001
- Website
- http://cj.hec.cn/
- Cybersecurity rating
Table of Contents
YiChang HEC ChangJiang Pharmaceutical Financials
Summary Financials
- Revenue (H1, 2024)
- ¥2.5B
- Gross profit (H1, 2024)
- ¥2.2B
- Net income (H1, 2024)
- ¥684.7M
- Cash (H1, 2024)
- ¥1.5B
- EBIT (H1, 2024)
- ¥839.8M
- Enterprise value
- $8.9B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2025